Global Scientific Affairs Director, Covid and Flu
Pfizer Inc.
Disclosure(s): Pfizer Inc.: Employee, Stocks/Bonds (Public Company)
Kayte Andersen is the Global Scientific Affairs Director for Covid and Flu and a pharmacoepidemiologist. At Pfizer, she implements causal inference and machine learning techniques to answer population-level questions related to Covid and flu disease burden, vaccines, therapeutic products and diagnostic tests. She holds a BSc in Pharmacology & Therapeutics from McGill University, an MSc focused on pharmacoepidemiology from McGill University, and a PhD in Epidemiology with a graduate certificate in pharmacoepidemiology and drug safety from the Johns Hopkins Bloomberg School of Public Health.